Altria Group (MO) Prix de l'Action, Cotation, Actualités et Historique | Benzinga

Altria Group Inc (MO) Prix de l'Action, Cotation, Actualités et Historique

MONYSE

Trade with Public

Trade with Public

$71.56

-0.1-0.14%

AperçuActualités Prévisions de résultats Événements Objectifs de cours Données financières Sentiment Actionnariat Dividendes Comparer Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Statistiques Clés

Ouverture

-

Clôture

$71.56

Volume / Moy.

- / 8.53M

Fourchette Journalière

- - -

Plage 52 Sem.

54.70 - 77.06

Capitalisation Boursière

$119.65B

Ratio P/E

15.07

Rendement des Dividendes

6.20%

Échange

NYSE

RSI

66

Intérêt à Découvert

2.26%

Jours pour Couvrir

4.7

Actualités Récentes de Altria Group Inc

Wall Street's Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields

Analysts highlight high-yield consumer staples Altria (6.59%), Clorox (6.22%) and General Mills (7.62%), with mixed ratings and targets.

Avi Kapoor

Wall Street's Most Accurate Analysts Give Their Take On 3 Risk Off Stocks Delivering High-Dividend Yields

Smithfield Foods, Altria and General Mills offer 6.32%-6.66% dividend yields, with recent analyst ratings, targets and company updates.

Avi Kapoor

They Bought Starbucks Stock in the '90s and Held Onto It. Now, They're Living Off the Dividends While People Spend a Fortune on Coffee

Imagine buying shares in a coffee chain in the 1990s, holding onto them for decades and eventually using the dividends to help fund your retirement. Now imagine doing all of that without actually drinking the

Adrian Volenik

Trump's Surgeon General Pick Has Tobacco, Cola Stocks In Portfolio Even as Robert Kennedy Jr. Wages War On Sugary Drinks, Processed Food

President Trump's Surgeon General nominee Dr. Nicole Saphier disclosed investments in Philip Morris and other companies, agreeing to divest if confirmed.

Radhika Anilkumar Nadig

Altria, Philip Morris Sign Manufacturing Pact

Altria and Philip Morris International enter a contract manufacturing deal to strengthen operating capabilities.

Akanksha Bakshi

Données financières

Trimestriel

Annuel

Nom

Revenu Changement
Brut Changement
EBITDA Changement
EBIT Changement
Bénéfices Changement

Flux de Trésorerie

Flux de Trésorerie Opérationnel (TTM)

9.41B

Flux de Trésorerie d'Investissement (TTM)

-428.00M

Flux de Trésorerie de Financement (TTM)

-7.91B

Flux de Trésorerie Libre (TTM)

9.11B

Dépenses en Capital (TTM)

-296.00M

Variation Nette de la Trésorerie (TTM)

1.07B

Tendances et prévisions des analystes

1

1

1

mai

1

juil.

1

août

Acheter

Conserver

Vendre

Vente forte

Évaluation et prévisions des analystes

2.7

Conserver

Achat fort

Acheter

Conserver

Vendre

Vente forte

Métriques de Valorisation

Valeur Entreprise

$141.70B

Ratio P/E (TTM)

15.07

Ratio P/E (FWD)

12.33

Ratio PEG (TTM)

2.74

Ratio P/S (TTM)

5.86

Ratio P/B (TTM)

-

Rendement des Bénéfices % (TTM)

6.64%

Rendement des Bénéfices % (FWD)

8.11%

EV / EBITDA (TTM)

12.00

Prix / EBITDA (TTM)

10.16

Prix / Flux de Trésorerie Libre (TTM)

13.16

Valeur Comptable / Action

-$1.60

Dette Entreprise

Dette Totale

$24.58B

Dette à Long Terme

$22.89B

Émission de Dette à Long Terme (TTM)

$995.00M

Remboursement de la Dette à Long Terme (TTM)

-$1.07B

Trésorerie Totale

$2.37B

Dette sur Capitaux Propres

-

Émission de Dette (TTM)

-$74.00M

Remboursement de la Dette (TTM)

-$1.07B